Bill Hendey

2.0k total citations
23 papers, 1.6k citations indexed

About

Bill Hendey is a scholar working on Molecular Biology, Immunology and Allergy and Cancer Research. According to data from OpenAlex, Bill Hendey has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Immunology and Allergy and 7 papers in Cancer Research. Recurrent topics in Bill Hendey's work include Cell Adhesion Molecules Research (11 papers), Protease and Inhibitor Mechanisms (6 papers) and Barrier Structure and Function Studies (5 papers). Bill Hendey is often cited by papers focused on Cell Adhesion Molecules Research (11 papers), Protease and Inhibitor Mechanisms (6 papers) and Barrier Structure and Function Studies (5 papers). Bill Hendey collaborates with scholars based in United States. Bill Hendey's co-authors include Paul M. Carvey, Frederick R. Maxfield, Claude B. Klee, Lynda M. Pierini, Robert J. Eddy, Moira A. Lawson, Julie A. Schneider, Peter Marks, Jialiang Li and Yanqiao Zhu and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Bill Hendey

23 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bill Hendey United States 16 628 424 389 319 277 23 1.6k
Sylvie Cazaubon France 22 1.2k 1.9× 542 1.3× 366 0.9× 303 0.9× 83 0.3× 35 2.3k
Pierluigi Baron Italy 20 405 0.6× 325 0.8× 134 0.3× 185 0.6× 177 0.6× 39 1.4k
Vera Novitskaya United Kingdom 23 1.2k 1.9× 172 0.4× 239 0.6× 322 1.0× 85 0.3× 28 1.9k
Michael J. Ignatius United States 11 795 1.3× 138 0.3× 302 0.8× 272 0.9× 100 0.4× 14 1.7k
Linda Ottoboni Italy 22 923 1.5× 660 1.6× 200 0.5× 90 0.3× 118 0.4× 57 2.5k
Roman Urfer United States 22 1.1k 1.8× 176 0.4× 129 0.3× 201 0.6× 74 0.3× 28 1.8k
Rudolf Fuchshofer Germany 31 1.5k 2.4× 245 0.6× 158 0.4× 455 1.4× 99 0.4× 64 3.0k
Hiroshi Mori Japan 23 961 1.5× 182 0.4× 64 0.2× 398 1.2× 291 1.1× 62 1.8k
Dominique Talabot Switzerland 4 729 1.2× 163 0.4× 209 0.5× 81 0.3× 71 0.3× 5 1.5k
Colin Niaudet United States 12 1.0k 1.6× 1.3k 3.0× 92 0.2× 282 0.9× 310 1.1× 17 2.7k

Countries citing papers authored by Bill Hendey

Since Specialization
Citations

This map shows the geographic impact of Bill Hendey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill Hendey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill Hendey more than expected).

Fields of papers citing papers by Bill Hendey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bill Hendey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill Hendey. The network helps show where Bill Hendey may publish in the future.

Co-authorship network of co-authors of Bill Hendey

This figure shows the co-authorship network connecting the top 25 collaborators of Bill Hendey. A scholar is included among the top collaborators of Bill Hendey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bill Hendey. Bill Hendey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toia, Giuseppe V., et al.. (2011). An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. Experimental Neurology. 231(1). 160–170. 14 indexed citations
2.
Schneider, Julie A., et al.. (2011). Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy. Journal of Neural Transmission. 119(1). 59–71. 101 indexed citations
3.
Carvey, Paul M., et al.. (2009). The blood–brain barrier in neurodegenerative disease: a rhetorical perspective. Journal of Neurochemistry. 111(2). 291–314. 183 indexed citations
4.
Schneider, Julie A., et al.. (2009). Evidence of angiogenic vessels in Alzheimer’s disease. Journal of Neural Transmission. 116(5). 587–597. 120 indexed citations
5.
Zhao, Chaohui, et al.. (2006). Evidence of blood–brain barrier disruption in Parkinson's disease (PD). Experimental Neurology. 198(2). 566–566. 1 indexed citations
6.
Carvey, Paul M., Chaohui Zhao, Bill Hendey, et al.. (2005). 6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability. European Journal of Neuroscience. 22(5). 1158–1168. 179 indexed citations
7.
Hendey, Bill, et al.. (2002). Fas activation opposes PMA-stimulated changes in the localization of PKCδ: a mechanism for reducing neutrophil adhesion to endothelial cells. Journal of Leukocyte Biology. 71(5). 863–870. 16 indexed citations
8.
Hendey, Bill, et al.. (2002). Fas activation opposes PMA-stimulated changes in the localization of PKCdelta: a mechanism for reducing neutrophil adhesion to endothelial cells.. PubMed. 71(5). 863–70. 17 indexed citations
9.
Fong, Miranda, et al.. (2000). Fas activation reduces neutrophil adhesion to endothelial cells. Journal of Leukocyte Biology. 68(5). 715–722. 19 indexed citations
10.
Pierini, Lynda M., Moira A. Lawson, Robert J. Eddy, Bill Hendey, & Frederick R. Maxfield. (2000). Oriented endocytic recycling of α5β1 in motile neutrophils. Blood. 95(8). 2471–2480. 120 indexed citations
11.
Pierini, Lynda M., Moira A. Lawson, Robert J. Eddy, Bill Hendey, & Frederick R. Maxfield. (2000). Oriented endocytic recycling of α5β1 in motile neutrophils. Blood. 95(8). 2471–2480. 116 indexed citations
12.
Malik, Asrar B., et al.. (1996). Fibronectin enhances the migration rate of human neutrophils in vitro. Journal of Leukocyte Biology. 60(2). 199–206. 56 indexed citations
15.
Hendey, Bill, Claude B. Klee, & Frederick R. Maxfield. (1992). Inhibition of Neutrophil Chemokinesis on Vitronectin by Inhibitors of Calcineurin. Science. 258(5080). 296–299. 170 indexed citations
16.
Hendey, Bill & Mark D. Mamrack. (1991). WS‐1 human fibroblasts contain distinct calcium and protein kinase C‐mediated pathways for activation of Na+/H+ exchange: Contrasting effects of thrombin and PMA. Journal of Cellular Physiology. 146(2). 290–297. 4 indexed citations
17.
Marks, Peter, Bill Hendey, & Frederick R. Maxfield. (1991). Attachment to fibronectin or vitronectin makes human neutrophil migration sensitive to alterations in cytosolic free calcium concentration.. The Journal of Cell Biology. 112(1). 149–158. 95 indexed citations
18.
Hendey, Bill, Mark D. Mamrack, & Robert W. Putnam. (1989). Thrombin induces a calcium transient that mediates an activation of the Na+/H+ exchanger in human fibroblasts. Journal of Biological Chemistry. 264(33). 19540–19547. 40 indexed citations
19.
Hendey, Bill & Mark D. Mamrack. (1988). Differential response of normal human fibroblasts to bombesin versus thrombin. Journal of Cellular Physiology. 136(3). 486–492. 8 indexed citations
20.
Hendey, Bill, et al.. (1981). Moral Judgments by Children of the Intentional Behavior of Friends and Strangers. The Journal of Genetic Psychology. 139(2). 227–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026